Raymond Douglas, MD, PhD: State of Thyroid Eye Disease in 2020

Oct 19, 2020, 11:13 AM

Headliner
Share
Subscribe
Raymond Douglas, MD, PhD, discusses trends in therapies and the current state of thyroid eye disease treatments in 2020.
Share
Subscribe
Next
Terri Lipman, PhD, CRNP: Addressing Racial Disparities in Medicine
Top episodes
Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD
by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tirzepatide for Weight Loss and Lowering HbA1c with Juan Frias, MD
by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Key Updates in ADA Standards of Care—2024
by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives